Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-02 Sale |
2022-08-04 9:01 pm |
Cullinan Oncology Inc. | CGEM | F2 Vision SCS Jovan-Embiricos Morana 10% Owner |
49,910 | $14.26 | $711,676 | 4,476,350 (Indirect Direct) |
View |
| 2022-06-21 Sale |
2022-06-23 6:47 pm |
Cullinan Oncology Inc. | CGEM | F2 Bioscience I 2017 Ltd Jovan-Embiricos Morana 10% Owner |
101,903 | $12.8 | $1,304,816 | 4,430,964 (Indirect Direct) |
View |
| 2022-05-12 Sale |
2022-05-16 8:54 pm |
Cullinan Oncology Inc. | CGEM | F2 Vision SCS Jovan-Embiricos Morana 10% Owner |
418,738 | $9.6619 | $4,045,791 | 4,532,867 (Indirect Direct) |
View |
| 2021-11-10 Sale |
2021-11-15 5:17 pm |
Allovir Inc. | ALVR | Jovan-Embiricos Morana Director |
800 | $24.77 | $19,812 | 17,005,545 (Indirect Direct) |
View |
| 2021-11-05 Sale |
2021-11-09 6:43 pm |
Allovir Inc. | ALVR | Jovan-Embiricos Morana Director |
12,196 | $24.8 | $302,455 | 17,005,665 (Indirect Direct) |
View |
| 2021-10-27 Sale |
2021-10-29 5:02 pm |
Allovir Inc. | ALVR | Jovan-Embiricos Morana Director |
2,200 | $24.78 | $54,511 | 17,007,494 (Indirect Direct) |
View |
| 2021-10-21 Sale |
2021-10-25 6:24 pm |
Allovir Inc. | ALVR | Jovan-Embiricos Morana Director |
13,592 | $24.8 | $337,045 | 17,007,824 (Indirect Direct) |
View |
| 2021-01-12 Purchase |
2021-01-14 5:30 pm |
Cullinan Management Inc. | CGEM | Jovan-Embiricos Morana Globeways Holdings Ltd F2 Vision SCS F2 Bioscience I 2017 Ltd F2 MG Ltd F2 - TPO Investments LLC F2 Bio TD LLC F2 MC LLC F2 GC LLC Director 10% Owner |
200,000 | $21 | $4,200,000 | 217,269 (Indirect Direct) |
View |
| 2020-08-03 Purchase |
2020-08-06 06:06 am |
Allovir Inc. | ALVR | Jovan-Embiricos Morana Director 10% Owner |
2,900,000 | $17 | $49,300,000 | 2,830,197 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-10 Option Award |
2025-04-11 5:08 pm |
N/A 2035-04-09 |
Kalaris Therapeutics Inc. | KLRS | Jovan-Embiricos Morana Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-07 4:05 pm |
N/A N/A |
Allovir Inc. | ALVR | Jovan-Embiricos Morana Director 10% Owner |
35,000 | $0 | 26,603,054 (Direct) |
View |
| 2023-05-11 Option Award |
2023-05-12 5:00 pm |
N/A N/A |
Allovir Inc. | ALVR | Jovan-Embiricos Morana Director 10% Owner |
35,000 | $0 | 23,661,793 (Direct) |
View |
| 2022-07-28 Option Award |
2022-08-01 4:35 pm |
N/A N/A |
Allovir Inc. | ALVR | Jovan-Embiricos Morana Director 10% Owner |
8,152,247 | $4.61 | 16,704,963 (Indirect) |
View |
| 2022-06-24 Exercise |
2022-06-28 9:24 pm |
N/A 2022-06-30 |
Cullinan Oncology Inc. | CGEM | Jovan-Embiricos Morana 10% Owner |
140,374 | $0 | 4,526,260 (Direct) |
View |
| 2022-06-24 Exercise |
2022-06-28 9:24 pm |
N/A N/A |
Cullinan Oncology Inc. | CGEM | Jovan-Embiricos Morana 10% Owner |
140,374 | $4.3 | 4,526,260 (Direct) |
View |
| 2022-06-24 Tax Withholding |
2022-06-28 9:24 pm |
N/A N/A |
Cullinan Oncology Inc. | CGEM | Jovan-Embiricos Morana 10% Owner |
45,078 | $13.39 | 4,526,260 (Direct) |
View |
| 2022-05-17 Option Award |
2022-05-19 4:28 pm |
N/A 2032-05-16 |
Allovir Inc. | ALVR | Jovan-Embiricos Morana Director 10% Owner |
27,500 | $0 | 27,500 (Direct) |
View |
| 2021-09-16 Option Award |
2022-03-25 7:32 pm |
N/A 2031-09-15 |
Cullinan Oncology Inc. | CGEM | Jovan-Embiricos Morana Director |
7,800 | $0 | 7,800 (Direct) |
View |
| 2022-01-11 Other |
2022-01-13 5:22 pm |
N/A N/A |
Cullinan Oncology Inc. | CGEM | F2 Vision SCS Jovan-Embiricos Morana 10% Owner |
1,187,734 | $0 | 2,912,345 (Direct) |
View |
| 2021-05-25 Option Award |
2021-05-27 4:45 pm |
N/A 2031-05-24 |
Allovir Inc. | ALVR | Jovan-Embiricos Morana Director 10% Owner |
22,500 | $0 | 22,500 (Direct) |
View |
| 2021-01-12 Conversion |
2021-01-14 5:30 pm |
N/A N/A |
Cullinan Management Inc. | CGEM | Jovan-Embiricos Morana Globeways Holdings Ltd F2 Vision SCS F2 Bioscience I 2017 Ltd F2 MG Ltd F2 - TPO Investments LLC F2 Bio TD LLC F2 MC LLC F2 GC LLC Director 10% Owner |
46,770,331 | $0 | 217,269 (Indirect) |
View |
Ownership |
2021-01-07 8:32 pm |
N/A N/A |
Cullinan Management Inc. | CGEM | Jovan-Embiricos Morana Globeways Holdings Ltd F2 Vision SCS F2 Bioscience I 2017 Ltd F2 MG Ltd F2 - TPO Investments LLC F2 Bio TD LLC F2 MC LLC Director 10% Owner |
0 | $0 | 6,079,713 (Direct) |
View |
| 2020-08-03 Conversion |
2020-08-06 06:06 am |
N/A N/A |
Allovir Inc. | ALVR | Jovan-Embiricos Morana Director 10% Owner |
38,546,881 | $0 | 2,830,197 (Indirect) |
View |
| 2020-07-29 Option Award |
2020-07-31 6:44 pm |
N/A 2030-07-29 |
Allovir Inc. | ALVR | Jovan-Embiricos Morana Director 10% Owner |
22,500 | $0 | 22,500 (Direct) |
View |
Ownership |
2020-07-30 07:35 am |
N/A N/A |
Allovir Inc. | ALVR | Jovan-Embiricos Morana Director 10% Owner |
0 | $0 | 15,509,595 (Direct) |
View |